DNC Pharma Revenue and Competitors
Estimated Revenue & Valuation
- DNC Pharma's estimated annual revenue is currently $25M per year.
- DNC Pharma's estimated revenue per employee is $210,000
Employee Data
- DNC Pharma has 119 Employees.
- DNC Pharma grew their employee count by -23% last year.
DNC Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder & Global CEO | Reveal Email/Phone |
2 | Co-Founder & CEO Turkey | Reveal Email/Phone |
3 | Data Scientist | Reveal Email/Phone |
DNC Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $106.8M | 407 | -12% | N/A | N/A |
#2 | $220.4M | 734 | -1% | $13.6M | N/A |
#3 | $23.1M | 110 | -2% | N/A | N/A |
#4 | $727.9M | 2476 | 10% | N/A | N/A |
#5 | $40M | 173 | 20% | N/A | N/A |
#6 | $26.7M | 127 | 4% | N/A | N/A |
#7 | $19.1M | 91 | -12% | N/A | N/A |
#8 | $11.2M | 59 | 5% | N/A | N/A |
#9 | $22.3M | 106 | 61% | N/A | N/A |
#10 | $20.6M | 98 | -21% | N/A | N/A |
What Is DNC Pharma?
Colendi helps consumers, merchants, and the financial institutions with its first bank-independent Credit Scoring, Micro Credit and financial services platform
keywords:N/AN/A
Total Funding
119
Number of Employees
$25M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
DNC Pharma News
2022-04-20 - Harvard report brings joy, grief for descendants of enslaved
DNC seeks to boost California election outreach ahead of anticipated ... PERRIGO ANNOUNCES EXPECTED TRANSACTION CLOSE DATE OF HRA PHARMA.
2022-04-20 - Doctor Strange' actress Zara Phythian accused of sex acts ...
DNC seeks to boost California election outreach ahead of anticipated ... PERRIGO ANNOUNCES EXPECTED TRANSACTION CLOSE DATE OF HRA PHARMA.
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.8M | 123 | 18% | N/A |
#2 | $25.1M | 125 | 18% | N/A |
#3 | $25.1M | 125 | 18% | N/A |
#4 | $16.5M | 127 | -23% | $108M |
#5 | $25.6M | 135 | 75% | N/A |
